Aspyra to Demonstrate Teleradiology and Interoperabilty with AccessRAD RIS/PACS at RSNA 2009
12 10월 2009 - 10:30PM
Business Wire
Aspyra, Inc. (AMEX: APY) today announced plans to
demonstrate the latest release of AccessRAD, their integrated
RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at
McCormick Place in Chicago, IL (November 29 – December 3, 2009),
Booth 3021, South Building Hall A.
The latest release of Aspyra’s AccessRAD RIS/PACS, version
6.5.0, includes performance improvement features for accessing and
reading radiological images and new methods for creating, printing,
and scanning of registration forms and modality questionnaires; an
improved scheduling process, and more efficient method of
rescheduling or canceling of patient exams. A key feature of
AccessRAD RIS/PACS v6.5 also features the ability to create
internal orders for studies sent from outside referring facilities
diagnostic interpretation via DICOM transfer protocols. These
orders are automatically are processed by the RIS, thereby
optimizing workflow, as well as increasing revenue by preventing
lost charges due to missing or incorrect orders. Reports created
for these outside studies can have tailored report templates which
retain the other facilities medical record and exam number. Once
signed by the radiologist the reports then can be automatically
sent back to the outside facility via fax or HL7 data
transmission.
Bill Culton, Aspyra’s Diagnostic Solutions Product Manager
states, “Many of our customers are forming relationships with
outside facilities to read studies for them. Our interoperability
with other PACS system allows them receive DICOM studies and have
our system automatically create internal orders from them giving
them a efficient and labor-less outside study workflow. We will
also be demonstrating our interoperability with RADAR a critical
results management system.”
Aspyra’s AccessRAD RIS/PACS (Radiology Information System /
Picture Archive Communication System) is designed to meet the needs
of acute care hospitals, enterprise-wide delivery networks, and
medium to large imaging centers, with end-to-end solutions that
automate processes at every point of patient and imaging encounter
workflow.
Safe Harbor
Statement
This press release includes forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995, including statements related to anticipated revenues,
expenses, earnings, operating cash flows, the outlook for Aspyra’s
markets and the demand for its products. Forward-looking statements
are not guarantees of future performance and are inherently subject
to uncertainties and other factors which could cause actual results
to differ materially from the forward-looking statement. Such
statements are based upon, among other things, assumptions made by,
and information currently available to, management as of today the
date of this press release, including management's own knowledge
and assessment of the Company’s industry and competition. Factors
that could cause Aspyra’s actual results to differ materially from
these forward-looking statements include among others: the
competitive environment; unexpected technical and marketing
difficulties inherent in major product development efforts; the
potential need for changes in our long-term strategy in response to
future developments; future advances in clinical information
technology and procedures, as well as potential changes in
government regulations and healthcare policies; and rapid
technological change in the microelectronics and software
industries. The Company refers interested persons to its most
recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q
and its other SEC filings for a description of additional
uncertainties and factors, which may affect forward-looking
statements. The Company assumes no duty to update its
forward-looking statements.
Aspyra (AMEX:APY)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Aspyra (AMEX:APY)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
